Status:
UNKNOWN
Development of Molecular Diagnostic Platform for Tuberculosis
Lead Sponsor:
Asan Medical Center
Conditions:
Tuberculosis
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
This study evaluates new technique for diagnosis of tuberculosis. Among patients who are suspected with tuberculosis, participants will be tested conventional method including Xpert TB/RIF assay, and ...
Eligibility Criteria
Inclusion
- Patients who are suspected with pulmonary tuberculosis, tuberculosis meningitis, tuberculosis peritonitis, tuberculosis pleurisy
Exclusion
- Under 18 years
Key Trial Info
Start Date :
January 28 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04734236
Start Date
January 28 2021
End Date
December 31 2021
Last Update
February 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center, University of Ulsan College of Medicine
Seoul, Songpa, South Korea, 05505